Learn more

CHANGSHA YINGRUN BIOTECHNOLOGY CO LTD

Overview
  • Total Patents
    15
  • GoodIP Patent Rank
    174,978
About

CHANGSHA YINGRUN BIOTECHNOLOGY CO LTD has a total of 15 patent applications. Its first patent ever was published in 2009. It filed its patents most often in China. Its main competitors in its focus markets biotechnology and pharmaceuticals are SHANGHAI ANIMAL EPIDEMIC PREVENTION AND CONTROL CENTER, CHINA ANIMAL HEALTH AND EPIDEMIOLOGY CENTER and NANJING PRACTICE MEDICINE EXAMINATION CO LTD.

Patent filings in countries

World map showing CHANGSHA YINGRUN BIOTECHNOLOGY CO LTDs patent filings in countries
# Country Total Patents
#1 China 15

Patent filings per year

Chart showing CHANGSHA YINGRUN BIOTECHNOLOGY CO LTDs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Wu Xiaoning 14
#2 Liu Caiyun 14
#3 Yi Yinsha 14
#4 Zhang Wanming 13
#5 Yuan Bingqiu 13
#6 Zhu Haiqiang 11
#7 Zou Yizhou 10
#8 Xu Peng 9
#9 Li Na 6
#10 Cao Pengrong 4

Latest patents

Publication Filing date Title
CN104998300A Peripheral blood stem cells and endothelial progenitor cells combined cardiovascular repair technique
CN104800242A Myeloperoxidase (MPO) guided cellular immunotherapy technique
CN104611367A Variable-temperature transfection technique
CN104593250A Flexible single-cell separator and separation culture technology
CN104593423A Building method and use of antineoplastic compound screening model
CN104293644A Assisting part for blood monocyte separation
CN104288178A DC-CIK treatment method for postoperative control of tumor cell migration
CN104293836A Making method of immune complex adsorption cells
CN103725779A Serum/plasmanon miRNA marker for diagnosing non-small cell lung cancer at early stage and application thereof
CN103952465A Plasma microRNA analysis based method for diagnosis of ovarian cancer
CN103725775A Method for fast detecting BRAF gene mutation with allele RNA (ribonucleic acid) isothermal amplification method
CN103725647A Method for separating mononuclear cell without autoantigen from peripheral blood of lupus erythematosus patient
CN103720719A Technology for treating lupus erythematosus by DC (dendritic cell) and Treg (T regulator cell)
CN103725648A Novel CTC (circulating tumor cell) enrichment technology and preparation method of kit
CN101993892A Eukaryotic expression vector for expressing shRNA (short hairpin Ribonucleic Acid) in manner of targeting in cancer cells